+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID06938100

Studying Genetic and Clinical Features Alongside Brain Imaging in CADASIL Patients

Led by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Updated on 2026-08-31

100

Participants Needed

2

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying CADASIL, a genetic condition affecting small blood vessels in the brain, by analyzing patients both retrospectively and prospectively. The goal is to understand how symptoms relate to genetic risks and specific brain imaging and biological markers. This study aims to classify patients by disease risk to help find personalized treatment targets. Participants with CADASIL will be observed over time without receiving experimental treatments, as this is an observational study. The research includes collecting genetic, clinical, biological, and neuroradiological data, focusing on the NOTCH3 gene mutation and deposits found in small vessels. The study tracks disease progression and risk factors for up to 30 months. During the study, participants will undergo assessments to deepen knowledge of their clinical and neuroradiological condition. Researchers will identify markers that may predict disease progression and examine how different mutations influence brain abnormalities. The main outcomes include improved understanding of CADASILs clinical features and potentially reversible risk factors, with follow-up lasting up to 30 months.

CONDITIONS

Brief Title

Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASIL

Research Team

A

Anna Bersano, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here